Tryptophan catabolism prevents maternal T cells from activating lethal anti-fetal immune responses
- 8 October 2001
- journal article
- review article
- Published by Elsevier in Journal of Reproductive Immunology
- Vol. 52 (1-2) , 5-13
- https://doi.org/10.1016/s0165-0378(01)00118-8
Abstract
No abstract availableKeywords
This publication has 10 references indexed in Scilit:
- Prevention of T cell–driven complement activation and inflammation by tryptophan catabolism during pregnancyNature Immunology, 2001
- Immunology at the Maternal-Fetal Interface: Lessons for T Cell Tolerance and SuppressionAnnual Review of Immunology, 2000
- Indoleamine 2,3-Dioxygenase Production by Human Dendritic Cells Results in the Inhibition of T Cell ProliferationThe Journal of Immunology, 2000
- INDOLEAMINE 2, 3 - DIOXYGENASE BLOCKADE PREVENTS SPONTANEOUS LIVER ALLOGRAFT TOLEROGENICITY IN THE MOUSE.Transplantation, 2000
- A Critical Role for Murine Complement Regulator Crry in Fetomaternal ToleranceScience, 2000
- Tryptophan catabolism and T-cell tolerance: immunosuppression by starvation?Immunology Today, 1999
- Inhibition of T Cell Proliferation by Macrophage Tryptophan CatabolismThe Journal of Experimental Medicine, 1999
- Prevention of Allogeneic Fetal Rejection by Tryptophan CatabolismScience, 1998
- Th 1-type immunity is incompatible with successful pregnancyImmunology Today, 1997
- Suppressive Cellular and Molecular Activities in Maternofetal Immune Interactions; Suppressor Cell Activity, Prostaglandins, and Alpha-FetoproteinsPublished by Springer Nature ,1997